|
| 37725515 | Poor oral health influences head and neck cancer patient survival: an International Head and Neck Cancer Epidemiology Consortium pooled analysis. | J Natl Cancer Inst | 2024 |
| 37725515 | Poor oral health influences head and neck cancer patient survival: an International Head and Neck Cancer Epidemiology Consortium pooled analysis. | J Natl Cancer Inst | 2024 |
| 36520995 | Human Immunodeficiency Virus Is Associated With Poor Overall Survival Among Patients With Head and Neck Cancer. | Clin Infect Dis | 2023 |
| 37625360 | Time to treatment patterns of head and neck cancer patients before and during the Covid-19 pandemic. | Oral Oncol | 2023 |
| 37767817 | Effect of distance of treatment center on survival for HPV-negative head and neck cancer patients. | Head Neck | 2023 |
| 36520995 | Human Immunodeficiency Virus Is Associated With Poor Overall Survival Among Patients With Head and Neck Cancer. | Clin Infect Dis | 2023 |
| 37395170 | A phase 2 study of neoadjuvant chemotherapy plus durvalumab in resectable locally advanced head and neck squamous cell carcinoma. | Cancer | 2023 |
| 37523561 | Noncanonical HPV carcinogenesis drives radiosensitization of head and neck tumors. | Proc Natl Acad Sci U S A | 2023 |
| 37625360 | Time to treatment patterns of head and neck cancer patients before and during the Covid-19 pandemic. | Oral Oncol | 2023 |
| 37523561 | Noncanonical HPV carcinogenesis drives radiosensitization of head and neck tumors. | Proc Natl Acad Sci U S A | 2023 |
| 37767817 | Effect of distance of treatment center on survival for HPV-negative head and neck cancer patients. | Head Neck | 2023 |
| 37395170 | A phase 2 study of neoadjuvant chemotherapy plus durvalumab in resectable locally advanced head and neck squamous cell carcinoma. | Cancer | 2023 |
| 34383306 | Assessing Human Papillomavirus Awareness and the Role of Oropharyngeal Squamous Cell Carcinoma Education on Improving Intention to Vaccinate. | Laryngoscope | 2022 |
| 36248736 | Erratum: Exploring APOBEC3A and APOBEC3B substrate specificity and their role in HPV positive head and neck cancer. | iScience | 2022 |
| 36164654 | Exploring ABOBEC3A and APOBEC3B substrate specificity and their role in HPV positive head and neck cancer. | iScience | 2022 |
| 35504112 | Activation of the CREB Coactivator CRTC2 by Aberrant Mitogen Signaling promotes oncogenic functions in HPV16 positive head and neck cancer. | Neoplasia | 2022 |
| 35634245 | NF-κB over-activation portends improved outcomes in HPV-associated head and neck cancer. | Oncotarget | 2022 |
| 36148399 | Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer. | Cancer Res Commun | 2022 |
| 36274024 | Corrigendum to "Diagnostic accuracy of FNA to determine HPV status in HPV-associated oropharyngeal squamous cell carcinoma" [Oral Oncol. 134 (2022) 106131]. | Oral Oncol | 2022 |
| 36074493 | Development of a Novel Molecular Test for Determining HPV Integration Status in HPV-Positive Oropharynx Cancers. | JAMA Otolaryngol Head Neck Surg | 2022 |
| 36139648 | Direct Comparison of HPV16 Viral Genomic Integration, Copy Loss, and Structural Variants in Oropharyngeal and Uterine Cervical Cancers Reveal Distinct Relationships to E2 Disruption and Somatic Alteration. | Cancers (Basel) | 2022 |
| 35731223 | Comprehensive Viral Genotyping Reveals Prognostic Viral Phylogenetic Groups in HPV16-Associated Squamous Cell Carcinoma of the Oropharynx. | Mol Cancer Res | 2022 |
| 35405498 | Characteristics and outcomes associated with anxiety and depression in a head and neck cancer survivorship cohort. | Am J Otolaryngol | 2022 |
| 36191480 | Diagnostic accuracy of FNA to determine HPV status in HPV-associated oropharyngeal squamous cell carcinoma. | Oral Oncol | 2022 |
| 33845657 | A 2020 Update on Public Awareness of Head and Neck Cancers. | Otolaryngol Head Neck Surg | 2022 |
| 35044015 | Socioeconomic status, access to care, risk factor patterns, and stage at diagnosis for head and neck cancer among black and white patients. | Head Neck | 2022 |
| 34793605 | Association of self-reported financial burden with quality of life and oncologic outcomes in head and neck cancer. | Head Neck | 2022 |
| 34980502 | Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma. | Eur J Cancer | 2022 |
| 34383306 | Assessing Human Papillomavirus Awareness and the Role of Oropharyngeal Squamous Cell Carcinoma Education on Improving Intention to Vaccinate. | Laryngoscope | 2022 |
| 35405498 | Characteristics and outcomes associated with anxiety and depression in a head and neck cancer survivorship cohort. | Am J Otolaryngol | 2022 |
| 35731223 | Comprehensive Viral Genotyping Reveals Prognostic Viral Phylogenetic Groups in HPV16-Associated Squamous Cell Carcinoma of the Oropharynx. | Mol Cancer Res | 2022 |
| 35504112 | Activation of the CREB Coactivator CRTC2 by Aberrant Mitogen Signaling promotes oncogenic functions in HPV16 positive head and neck cancer. | Neoplasia | 2022 |
| 35634245 | NF-κB over-activation portends improved outcomes in HPV-associated head and neck cancer. | Oncotarget | 2022 |
| 36248736 | Erratum: Exploring APOBEC3A and APOBEC3B substrate specificity and their role in HPV positive head and neck cancer. | iScience | 2022 |
| 36148399 | Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer. | Cancer Res Commun | 2022 |
| 36074493 | Development of a Novel Molecular Test for Determining HPV Integration Status in HPV-Positive Oropharynx Cancers. | JAMA Otolaryngol Head Neck Surg | 2022 |
| 36274024 | Corrigendum to "Diagnostic accuracy of FNA to determine HPV status in HPV-associated oropharyngeal squamous cell carcinoma" [Oral Oncol. 134 (2022) 106131]. | Oral Oncol | 2022 |
| 36139648 | Direct Comparison of HPV16 Viral Genomic Integration, Copy Loss, and Structural Variants in Oropharyngeal and Uterine Cervical Cancers Reveal Distinct Relationships to E2 Disruption and Somatic Alteration. | Cancers (Basel) | 2022 |
| 36164654 | Exploring ABOBEC3A and APOBEC3B substrate specificity and their role in HPV positive head and neck cancer. | iScience | 2022 |
| 36191480 | Diagnostic accuracy of FNA to determine HPV status in HPV-associated oropharyngeal squamous cell carcinoma. | Oral Oncol | 2022 |
| 33845657 | A 2020 Update on Public Awareness of Head and Neck Cancers. | Otolaryngol Head Neck Surg | 2022 |
| 35044015 | Socioeconomic status, access to care, risk factor patterns, and stage at diagnosis for head and neck cancer among black and white patients. | Head Neck | 2022 |
| 34980502 | Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma. | Eur J Cancer | 2022 |
| 34793605 | Association of self-reported financial burden with quality of life and oncologic outcomes in head and neck cancer. | Head Neck | 2022 |
| 33170518 | Socioeconomic Status Drives Racial Disparities in HPV-negative Head and Neck Cancer Outcomes. | Laryngoscope | 2021 |
| 34161897 | Prognostic impact of socioeconomic status compared to overall stage for HPV-negative head and neck squamous cell carcinoma. | Oral Oncol | 2021 |
| 33819343 | Genomic heterogeneity and copy number variant burden are associated with poor recurrence-free survival and 11q loss in human papillomavirus-positive squamous cell carcinoma of the oropharynx. | Cancer | 2021 |
| 33710132 | Clinical Outcomes of Patients With pT1-T2N0 Oral Tongue Squamous Cell Carcinoma. | Am J Clin Oncol | 2021 |
| 33170518 | Socioeconomic Status Drives Racial Disparities in HPV-negative Head and Neck Cancer Outcomes. | Laryngoscope | 2021 |
| 34926976 | Evaluation of Patient-Reported Delays and Affordability-Related Barriers to Care in Head and Neck Cancer. | OTO Open | 2021 |